← Back to Search

TSX dental implant system for Tooth Loss (Xpresso Trial)

N/A
Recruiting
Research Sponsored by ZimVie
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group

Summary

A prospective, observational, multicenter study where 62 patients needing implants in the maxilla or mandible will be enrolled. The patients will be restored with a final prosthesis no later than 4 months following implant placement surgery. The patients will come back for follow-up evaluations yearly for 2 years.

Eligible Conditions
  • Tooth Loss

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The number of implants that reach integration success/ implant survival at 2 years; the number of implants reaching primary stability during placement
Secondary study objectives
The change in bone level (crestal bone regression) measured and compared at various study visits for each study implant

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: TSX dental implant systemExperimental Treatment1 Intervention
treatment of tooth loss with TSX dental implants

Find a Location

Who is running the clinical trial?

ZimVieLead Sponsor
26 Previous Clinical Trials
2,340 Total Patients Enrolled
1 Trials studying Tooth Loss
60 Patients Enrolled for Tooth Loss
~41 spots leftby Dec 2026